![FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest - Vallet‐Pichard - 2007 - Hepatology - Wiley Online Library FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest - Vallet‐Pichard - 2007 - Hepatology - Wiley Online Library](https://aasldpubs.onlinelibrary.wiley.com/cms/asset/49de8154-4815-4c63-b344-addf571781dc/mfig001.jpg)
FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest - Vallet‐Pichard - 2007 - Hepatology - Wiley Online Library
![The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care | SpringerLink The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11606-021-07341-z/MediaObjects/11606_2021_7341_Fig1_HTML.png)
The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care | SpringerLink
![Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic](https://www.mdpi.com/life/life-11-00143/article_deploy/html/images/life-11-00143-g002.png)
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
![Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @ Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @](https://pbs.twimg.com/media/FTddTdTXEAE__xR.jpg)
Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @
![Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic](https://www.mdpi.com/life/life-11-00143/article_deploy/html/images/life-11-00143-g003.png)
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
![The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0929664621003442-gr1.jpg)
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
![Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease | Article Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease | Article](https://assets.cureus.com/uploads/figure/file/245411/lightbox_b70ae910f6d311ebafb4fd40bdb504f2-FIGURE-2.png)
Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease | Article
![Frontiers | Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population Frontiers | Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population](https://www.frontiersin.org/files/Articles/1024836/fmed-09-1024836-HTML/image_m/fmed-09-1024836-t003.jpg)
Frontiers | Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
![Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/320-1/optimal-cutoffs-sensitivity-specificity-positive-predictive-value-negative-predictive-value.jpg)
Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
![Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients - ScienceDirect Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0168827815007709-fx2.jpg)
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients - ScienceDirect
![Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00535-021-01796-x/MediaObjects/535_2021_1796_Fig2_HTML.png)
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink
![American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice](https://www.endocrinepractice.org/cms/attachment/38af0df8-dbf6-4ed0-9a1f-d5dfc28ffad7/gr1_lrg.jpg)
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings - Endocrine Practice
![Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online](https://cdn.hepatitisc.uw.edu/doc/94-4/scoring-systems-histologic-stage-fibrosis.jpg)